New study reveals optimal drug sequencing for postmenopausal osteoporosis treatment

The effectiveness and safety of available sequential treatments for the long-term management of postmenopausal osteoporosis.

Westlake’s non-opioid pain startup Latigo gets new leader; Ron Cooper lands next CEO gig at enGene

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 27, 2024

Urgent strategies needed to fight artemisinin resistance in East Africa

Artemisinin-based combination therapies (ACTs) have become the cornerstone of malaria treatment and control.

July 19, 2024

PharmAla Launches MDMA Clinical Trial Tool for Researchers | Psychedelic Invest

TORONTO, Aug. 22, 2024 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research,

August 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.